يعرض 1 - 10 نتائج من 761 نتيجة بحث عن '"MULTIPLE-MYELOMA"', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8

    المساهمون: CHU Lille, Leeds Institute of Cancer and Pathology [U.K.], The Levine Cancer Institute, Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Mayo Clinic [Rochester], University of Southern Denmark (SDU), Centre hospitalier universitaire de Nantes (CHU Nantes), University of Calgary, University of Wolverhampton, Karolinska University Hospital [Stockholm], Karolinska Institute, UniversitätsKlinikum Heidelberg, University of Melbourne, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Alberta, Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Massachusetts General Hospital [Boston], Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Henri Mondor [Créteil], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Janssen Research & Development, Amsterdam UMC - Amsterdam University Medical Center, This study was sponsored by Janssen Research & Development, LLC. The authors thank the patients who participated in this study and their families, as well as the study co-investigators, research nurses, and coordinators at each of the clinical sites. Medical writing and editorial support were provided by Grace Wang, PharmD, of Cello Health Communications/MedErgy, and were funded by Janssen Global Services, LLC., Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Henri Mondor, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Amsterdam UMC, Hematology, CCA - Cancer Treatment and quality of life, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Jonchère, Laurent

    المصدر: Leukemia
    Leukemia, 2022, 36 (4), pp.1066-1077. ⟨10.1038/s41375-021-01488-8⟩
    Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2022, ⟨10.1038/s41375-021-01488-8⟩
    Leukemia, 36(4), 1066-1077. Nature Publishing Group
    Facon, T, Cook, G, Usmani, S Z, Hulin, C, Kumar, S, Plesner, T, Touzeau, C, Bahlis, N J, Basu, S, Nahi, H, Goldschmidt, H, Quach, H, Mohty, M, Venner, C P, Weisel, K, Raje, N, Hebraud, B, Belhadj-Merzoug, K, Benboubker, L, Decaux, O, Manier, S, Caillot, D, Ukropec, J, Pei, H, van Rampelbergh, R, Uhlar, C M, Kobos, R & Zweegman, S 2022, ' Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA ', Leukemia, vol. 36, no. 4, pp. 1066-1077 . https://doi.org/10.1038/s41375-021-01488-8Test
    Facon, T, Cook, G, Usmani, S Z, Hulin, C, Kumar, S, Plesner, T, Touzeau, C, Bahlis, N J, Basu, S, Nahi, H, Goldschmidt, H, Quach, H, Mohty, M, Venner, C P, Weisel, K, Raje, N, Hebraud, B, Belhadj-Merzoug, K, Benboubker, L, Decaux, O, Manier, S, Caillot, D, Ukropec, J, Pei, H, Van Rampelbergh, R, Uhlar, C M, Kobos, R & Zweegman, S 2022, ' Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA ', Leukemia, vol. 36, pp. 1066-1077 . https://doi.org/10.1038/s41375-021-01488-8Test

    وصف الملف: application/pdf

  9. 9
  10. 10

    المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Anatomy and neurosciences

    المصدر: Leukemia, 36(5), 1371-1376. Nature Publishing Group
    Mateos, M-V, Weisel, K, de Stefano, V, Goldschmidt, H, Delforge, M, Mohty, M, Cavo, M, Vij, R, Lindsey-Hill, J, Dytfeld, D, Angelucci, E, Perrot, A, Benjamin, R, van de Donk, N W C J, Ocio, E M, Scheid, C, Gay, F, Roeloffzen, W, Rodriguez-Otero, P, Broijl, A, Potamianou, A, Sakabedoyan, C, Semerjian, M, Keim, S, Strulev, V, Schecter, J M, Vogel, M, Wapenaar, R, Nesheiwat, T, San-Miguel, J, Sonneveld, P, Einsele, H & Moreau, P 2022, ' LocoMMotion : a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma ', Leukemia, vol. 36, no. 5, pp. 1371-1376 . https://doi.org/10.1038/s41375-022-01531-2Test

    وصف الملف: application/pdf; Print-Electronic